← Back to Search

Imaging Device

Ultrasound vs Veinviewer for Difficult IV Access

N/A

Waitlist Available

Led By Quincy Tran, MD, PhD

Research Sponsored by University of Maryland, Baltimore

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who request Ultrasound guided peripheral IV (USGPIV)

Patients who are oriented to self (correct last name, first name), place (correct name of hospital), time (correct day of week or month of year) and person (correct name of current president)

Must not have

Patients with hemodynamically instability requiring rapid central access

Patients under 18 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 40 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare the ultrasound machine and the Vein Viewer, a near-infrared device, to see which is more efficient in helping patients with difficult intravenous access in emergency departments.

Who is the study for?

This trial is for patients who have trouble getting IVs placed because their veins are hard to see or feel. They must be able to identify themselves, the hospital, the date, and the current president. Only English speakers who can consent and aren't intoxicated or confused can join.

What is being tested?

The study compares two devices used to help insert IVs in difficult cases: an ultrasound machine (Zonare) and a near-infrared device called Veinviewer. It aims to find out which one is more efficient in an emergency department setting.

What are the potential side effects?

There may not be direct side effects from using Zonare or Veinviewer as they are non-invasive imaging technologies; however, discomfort or complications related to multiple attempts at IV insertion might occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am asking for an ultrasound-guided IV.

Select...

I know my name, where I am, the date, and the current president.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I need immediate medical intervention due to unstable blood pressure or heart rate.

Select...

I am under 18 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 40 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~40 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 40 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Operator's time

Secondary study objectives

Cannulation time

ED length of stay

IV size

+6 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: ZonareExperimental Treatment1 Intervention

108 patients are randomized to receive the intervention of using ultrasound machine (Zonare ZS3 machine) for IV cannulation. These patients will first undergo IV cannulation with assistance of the ultrasound machine.

Group II: VeinviewerExperimental Treatment1 Intervention

108 Patients are randomized to receive the Intervention of using the Veinviewer Flex machine for IV cannulation. These patients will first undergo IV cannulation with assistance of the Veinviewer Flex machine.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Veinviewer

2010

Completed Phase 4

~400

0 / 4Eligibility criteria met